Herwenda
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Herwenda, covering 2025-10-20 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Herwenda (trastuzumab) — Sandoz GmbH
2 regulatory and trial events tracked for Herwenda, covering 2025-10-20 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Herwenda (trastuzumab) — Sandoz GmbH